Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Fangzhou Luo, Mengxia Li, Jun Ding, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Advances in the surgical treatment of liver cancer
Harufumi Maki, Kiyoshi Hasegawa
BioScience Trends (2022) Vol. 16, Iss. 3, pp. 178-188
Open Access | Times Cited: 76
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park, Su Jong Yu
The Ewha Medical Journal (2025) Vol. 48, Iss. 1
Open Access
Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study
Sang Min Lee, Jin Hwa Choi, Jung‐Hwan Yoon, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Radiotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion chemotherapy of RALOX versus FOLFOX for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score-matching cohort study
Hao-Yang Tan, Shuangquan Liu, Yanhan Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Anxiety is a risk prognosis factor for hepatocellular carcinoma with portal vein tumor thrombus who underwent hepatic arterial infusion chemotherapy: a propensity score-matching cohort study
Hao-Yang Tan, Shuangquan Liu, Yanhan Liu, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma
Hua Yang, Mu-Zi-he Zhang, Huiwei Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus
Zeyu Zhang, Chan Li, Weijun Liao, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3619-3619
Open Access | Times Cited: 14
Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
Bin Guo, Qian Chen, Zhicheng Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma
Frederik Peeters, Jeroen Dekervel
Current Opinion in Pharmacology (2023) Vol. 70, pp. 102365-102365
Closed Access | Times Cited: 7
Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma
Min Zhang, Qiuhui Ding, Chenbin Bian, et al.
Experimental Cell Research (2023) Vol. 426, Iss. 1, pp. 113563-113563
Closed Access | Times Cited: 7
Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery
Wei Huang, Suosu Wei, Dong Xiao-feng, et al.
Cancer Biomarkers (2023) Vol. 39, Iss. 1, pp. 15-26
Open Access | Times Cited: 6
CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus
Sihang Cheng, Ge Hu, Zhengyu Jin, et al.
European Radiology (2023) Vol. 33, Iss. 12, pp. 8715-8726
Closed Access | Times Cited: 6
Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis
Long-Wang Lin, Leye Yan, Kun Ke, et al.
Brachytherapy (2023) Vol. 22, Iss. 6, pp. 858-871
Closed Access | Times Cited: 6
Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
Jeong Il Yu, Wonseok Kang, Gyu Sang Yoo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Dual acting acid-cleavable self-assembling prodrug from hyaluronic acid and ciprofloxacin: A potential system for simultaneously targeting bacterial infections and cancer
Usri H. Ibrahim, Nikita Devnarain, Mahir M. Sharif, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 546-561
Closed Access | Times Cited: 8
Transarterial chemoembolization for hepatocellular carcinoma with vascular invasion
Shiro Miyayama, Yasuaki Arai, Osamu Matsui
British Journal of Radiology (2022) Vol. 95, Iss. 1138
Open Access | Times Cited: 7
Portal Vein Thrombosis in Patients with Cirrhosis
Peter L. Wang, Vijay Ramalingam, Lauren M. Yang
Current Hepatology Reports (2024) Vol. 23, Iss. 1, pp. 64-72
Closed Access | Times Cited: 1
LINC01134: a pivotal oncogene with promising predictive maker and therapeutic target in hepatocellular carcinoma
Yutian Yu, Jialing Wang, QingFa Guo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis
Kaiwu Xu, Cai‐Ling Xiang, Zhige Yu, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 305-317
Open Access | Times Cited: 1
Nir-triggered arsenic-loaded layered double hydroxide-based films for localized thermal synergistic chemotherapy
Shun Xing, Haifeng Zhang, Zhenhao Hou, et al.
Journal of Colloid and Interface Science (2024) Vol. 675, pp. 857-869
Closed Access | Times Cited: 1
Intelligent Hydrogel-Assisted Hepatocellular Carcinoma Therapy
Zixiang Tang, Linhong Deng, Jin Zhang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 1
Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study
Shicong Zeng, Zongwen Wang, Qiankun Zhu, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 1, pp. 93-112
Open Access | Times Cited: 3
Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors
Tianyu Jiao, Haowen Tang, Wenwen Zhang, et al.
BMC Surgery (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
Chengjian He, Naijian Ge, Xiangdong Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: A long-term real-world study
Meng Sha, Chen Chen, Chuan Shen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top